These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
925 related articles for article (PubMed ID: 21752874)
1. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Hutchinson MR; Shavit Y; Grace PM; Rice KC; Maier SF; Watkins LR Pharmacol Rev; 2011 Sep; 63(3):772-810. PubMed ID: 21752874 [TBL] [Abstract][Full Text] [Related]
2. Opioid-induced central immune signaling: implications for opioid analgesia. Grace PM; Maier SF; Watkins LR Headache; 2015 Apr; 55(4):475-89. PubMed ID: 25833219 [TBL] [Abstract][Full Text] [Related]
3. Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids. Thomas J; Hutchinson MR Expert Rev Neurother; 2012 Nov; 12(11):1311-24. PubMed ID: 23234393 [TBL] [Abstract][Full Text] [Related]
5. Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility. Zhang P; Yang M; Chen C; Liu L; Wei X; Zeng S Front Immunol; 2020; 11():1455. PubMed ID: 32733481 [TBL] [Abstract][Full Text] [Related]
6. Opioid Receptors. Stein C Annu Rev Med; 2016; 67():433-51. PubMed ID: 26332001 [TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction. Jacobsen JH; Watkins LR; Hutchinson MR Int Rev Neurobiol; 2014; 118():129-63. PubMed ID: 25175864 [TBL] [Abstract][Full Text] [Related]
8. Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids. Watkins LR; Hutchinson MR; Ledeboer A; Wieseler-Frank J; Milligan ED; Maier SF Brain Behav Immun; 2007 Feb; 21(2):131-46. PubMed ID: 17175134 [TBL] [Abstract][Full Text] [Related]
9. Peripherally acting opioids and clinical implications for pain control. Sehgal N; Smith HS; Manchikanti L Pain Physician; 2011; 14(3):249-58. PubMed ID: 21587328 [TBL] [Abstract][Full Text] [Related]
10. Nociceptin, endogenous opioid peptide. Preface. Litwack G Vitam Horm; 2015; 97():xv-xvi. PubMed ID: 25677779 [No Abstract] [Full Text] [Related]
11. Addressing opioid tolerance and opioid-induced hypersensitivity: Recent developments and future therapeutic strategies. Khan F; Mehan A Pharmacol Res Perspect; 2021 May; 9(3):e00789. PubMed ID: 34096178 [TBL] [Abstract][Full Text] [Related]
13. Replacement of current opioid drugs focusing on MOR-related strategies. Busserolles J; Lolignier S; Kerckhove N; Bertin C; Authier N; Eschalier A Pharmacol Ther; 2020 Jun; 210():107519. PubMed ID: 32165137 [TBL] [Abstract][Full Text] [Related]
14. Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. DeLeo JA; Tanga FY; Tawfik VL Neuroscientist; 2004 Feb; 10(1):40-52. PubMed ID: 14987447 [TBL] [Abstract][Full Text] [Related]
15. The multitarget opioid ligand LP1's effects in persistent pain and in primary cell neuronal cultures. Parenti C; Turnaturi R; Aricò G; Gramowski-Voss A; Schroeder OH; Marrazzo A; Prezzavento O; Ronsisvalle S; Scoto GM; Ronsisvalle G; Pasquinucci L Neuropharmacology; 2013 Aug; 71():70-82. PubMed ID: 23541722 [TBL] [Abstract][Full Text] [Related]
16. Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence. Coller JK; Hutchinson MR Pharmacol Ther; 2012 May; 134(2):219-45. PubMed ID: 22316499 [TBL] [Abstract][Full Text] [Related]
17. The ambiguity of opioids revealed by immunology is changing the knowledge and the therapeutic approach in cancer and non-cancer pain: A narrative review. Santoni A; Arcuri E Immunol Lett; 2020 Oct; 226():12-21. PubMed ID: 32590120 [TBL] [Abstract][Full Text] [Related]